Shopping Cart
Remove All
Your shopping cart is currently empty
Anticancer agent 195
😃Good
Catalog No. T209334
Anticanceragent 195 (Compound 10) acts as an ELF3-MED23 PPI inhibitor with a Ki of 0.68 μM. It induces apoptosis and exhibits antitumor activity.
Anticancer agent 195
Anticancer agent 195
😃Good
Catalog No. T209334
Anticanceragent 195 (Compound 10) acts as an ELF3-MED23 PPI inhibitor with a Ki of 0.68 μM. It induces apoptosis and exhibits antitumor activity.
| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 10 mg | Inquiry | Inquiry | Inquiry | |
| 50 mg | Inquiry | Inquiry | Inquiry |
Add to Quotation
In Stock Estimated shipping dateUSA Warehouse[1-2 days] Global Warehouse[5-7 days]
All TargetMol products are for research purposes only and cannot be used for human consumption. We do not provide products or services to individuals. Please comply with the intended use and do not use TargetMol products for any other purpose.
Resource Download
Product Introduction
Bioactivity
Chemical Properties
Storage & Solubility Information
| Description | Anticanceragent 195 (Compound 10) acts as an ELF3-MED23 PPI inhibitor with a Ki of 0.68 μM. It induces apoptosis and exhibits antitumor activity. |
| In vitro | Anticancer agent 195 (10 μM) hinders the interaction between ELF3 and MED23, inhibits the activity of the HER2 promoter, and reduces AKT and MAPK phosphorylation. Additionally, in NCI-N87 cells, this agent exhibits antiproliferative effects and promotes apoptosis, effectively overcoming resistance to trastuzumab. |
| In vivo | The anticancer agent 195, administered at a dosage of 4 mg/kg through intravenous injection over a period of 25 days, inhibits tumor growth in athymic nude mice with NCI-N87 xenografts. |
| Formula | C24H28O6 |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
Calculator
In Vivo Formulation Calculator (Clear solution)
Please enter your animal experiment information in the following box and click Calculate to obtain the stock solution preparation method and in vivo formula preparation method:
For example, if the intended dosage is 10 mg/kg for animals weighing 20 g , with a dosing volume of 100 μL per animal, and a total of 10 animals are to be administered, using a formulation of 
10% DMSO+ 40% PEG300+ 5% Tween 80+ 45% Saline/PBS/ddH2O , the resulting working solution concentration would be 2 mg/mL.Stock Solution Preparation:
Dissolve 2 mg of the compound in 100 μL DMSO to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.
Preparation of the In Vivo Formulation:
1) Add 100 μL of the DMSO stock solution to 400 μL PEG300 and mix thoroughly until the solution becomes clear.
2) Add 50 μL Tween 80 and mix well until fully clarified.
3) Add 450 μL Saline,PBS or ddH2O and mix thoroughly until a homogeneous solution is obtained.
This example is provided solely to demonstrate the use of the In Vivo Formulation Calculator and does not constitute a recommended formulation for any specific compound. Please select an appropriate dissolution and formulation strategy based on your experimental model and route of administration.
Dose Conversion
You can also refer to dose conversion for different animals. More Dose Conversion
Tech Support
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc
Preview
Related Tags: buy Anticancer agent 195 | purchase Anticancer agent 195 | Anticancer agent 195 cost | order Anticancer agent 195 | Anticancer agent 195 in vivo | Anticancer agent 195 in vitro | Anticancer agent 195 formula
Generate Quote
Catalog No.: Cas No.:
Add
| Size | Quantity | Unit Price | Amount | Operation |
|---|
Generate Quote
- TOP
Feedback
Hello! How can I help you today? 
Copyright © 2015-2026 TargetMol Chemicals Inc. All Rights Reserved.